A proprietary formulation and an ionizable lipid chemical library that achieve or even surpass the delivery efficacy of Moderna's SM-102 ionizable lipid and formulation in animals.

Above shows the imaging results 24 hours after injection in mice of Firefly Luciferase mRNA delivered using different LNP delivery systems.

H1-H2 are self-developed ionizable lipids, prepared using a proprietary LNP formulation process.

Control 1 uses SM-102 lipid with the Moderna COVID-19 vaccine LNP formulation.

Control 2 uses SM-102 lipid with a proprietary LNP formulation.